Advertisement

Topics

Mitsubishi Tanabe Pharma gets approval for Canalia combination tablets in Japan

19:00 EDT 3 Jul 2017 | Pharmaceutical Technology

Japanese firm Mitsubishi Tanabe Pharma’s combination drug application has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for the manufacturing and sale of Canalia combination tablets for the treatment of an indicati…

Original Article: Mitsubishi Tanabe Pharma gets approval for Canalia combination tablets in Japan

NEXT ARTICLE

More From BioPortfolio on "Mitsubishi Tanabe Pharma gets approval for Canalia combination tablets in Japan"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...